About Sermorelin
A 29-amino-acid GHRH analogue studied for stimulating natural pituitary growth hormone release in a physiologic pulsatile pattern.
Research dose ranges
- Dose: 100–500 mcg per administration
- Frequency: 1× per day
- Route: subcutaneous
- Half-life: ~0.25 hours
- Cycle: 12 weeks on / 4 off
Research protocols typically administer 100–500 mcg subcutaneously once daily at bedtime to align with the natural nocturnal GH surge. Fasting prior to injection is recommended in most protocols to avoid blunting of the GH pulse.
Storage
Store lyophilized vials at 2–8°C. Once reconstituted, refrigerate and use within 30 days. Protect from light and freezing.